A stock with a large yield to offer – NAC

NAOS EX-50 OPPORTUNITIES COMPANY LIMITED

NAOS EX-50 OPPORTUNITIES COMPANY LIMITED (ASX: NAC) is an investment company which is engaged primarily in the mid-cap listed equities in both domestic and international markets. Derivatives and listed investments are the areas the company invests in. It caters to Consumer discretionary, industrials, mining, energy, financial services and insurance, consumer staples, healthcare, real estate and telecommunication services’ related sectors. It also offers a dividend reinvestment plan. An investment manager to the company is NAOS Asset Management Limited.

Updates and Financials:

For Naos Asset Management the year has been tough, and for the last three to four months the company’s two key funds did practically zero compared to 11 percent and 8 percent in the first half of the year. The market prices surged at the end of the year making the stock one of the most expensive stocks in the market. Because the chief investment officer, Evans believes the aged-care thematic is significant, Naos also invested in Japara Healthcare and believes that Japara is best to get the quality up. Consolidated Operations Group is another stock it has backed in finance broking business and Enero which reports in public relations the creative sector and technology. After raising just over $17 million, the company has launched the first listed investment company in 2013. With 8000 investors, it now has around $350 million across its listed investment companies. The company has a high concentration and conviction style of investments in the Australian listed companies outside of ASX50.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The Naos Emerging Opportunities Company, the Naos Ex-50 Opportunities Company, and the Naos Small Cap Opportunities Company are the three listed investment companies, managed by Naos Asset Management. The company has reported a $3.9 million after-tax profit for FY 18 and has seen a positive 67.21% increase in the investment portfolio performance since inception while 10.25% increase in FY18 of the investment portfolio performance was noted. The company has declared for the fourth consecutive period a record 5.25 cents per share, an increase of 5% on the prior comparative period. As per the FY 18 final dividend and Dividend Reinvestment Plan, the ex-dividend date stands at September 3, 2018, and record date as September 4, 2018, and payment date as September 19, 2018. The updated 70% of the portfolio is represented by top 5 holdings. The company has an annual dividend yield of 5.28% which is fully franked. The price to earnings ratio stands at 17.830 and the earnings per share at AUD 0.056. The market capitalization of the stock is $52.27 million as at August 23, 2018.

Stock Movements:

The stock of the company was trading at a market price of $1.010 as on August 23, 2018 and has seen a daily price change or a rise of $0.015 or a percentage change of 1.508%. The stock has seen a performance change of -2.45% over the past 12 months.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report